Diaxonhit SA (LSE:0O4T) - Share price - Overview

Stock Report

Diaxonhit SA 0O4T

Last Price
£-

Day Change
-|-%

As of -
- | GBP
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap-
52-Wk Range-
Yield %-
ISINFR0013240934
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201320142015
More ...
Income Statement
Revenue30.7531.2929.88
Operating Income-6.78-5.38-8.03
Net Income-5.99-5.49-5.88
Basic EPS-2.20-1.80-1.60
Avg. Diluted Shares Outstanding334
Balance Sheet
Current Assets15.9524.2221.41
Non Current Assets17.4716.2714.30
Total Assets33.4140.5035.71
Current Liabilities10.539.8910.16
Total Liabilities12.8520.5818.58
Total Equity20.5619.9217.13
Cash Flow
Operating Cash Flow-4.90-3.39-2.44
Capital Expenditure-0.57-0.66-0.16
Free Cash Flow-5.48-4.04-2.60

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Diaxonhit SA, through its subsidiary sells and provides after-sale service, under exclusivity contracts for the latest in-vitro diagnostic kits and processing devices in transplantation, infectious diseases, and autoimmunity, and quality control products.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

111
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)80.48
EPS Growth (3 year avg)-
Operating Margin % TTM-26.89
Net Margin % TTM-19.68
ROE TTM-31.74
Debt/Equity0.36
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.